4523 On Other Exchanges
4523 is not on other exchanges.

Executive Profile*

Haruo Naito

Chief Executive Officer, Representative Corporate Officer and Director,Eisai Co., Ltd.
AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2016


Mr. Haruo Naito has been the Chief Executive Officer of Eisai Co., Ltd. at Eisai, Inc. since June 2003 and has been its Representative Corporate Officer since June 2004. Mr. Naito has been President of Genox Research, Inc. since March 1996 and Drug Delivery System Institute, Ltd. since June 2003. He joined Eisai Co. Ltd. in October 1975 and became its Managing Director in June 1985; Representative Director and Senior Managing Director in June 1986; and Deputy President ...

Read Full Background

Corporate Headquarters*

4-6-10, Koishikawa
Tokyo, -- 112-8088


Phone: 81 3 3817 3016
Fax: 81 3 3811 6032

Board Members Memberships*

Chief Executive Officer, Representative Corporate Officer and Director


There is no Education data available.

Other Affiliations*

Annual Compensation*

Total Annual Compensation¥142,000,000

Stock Options*

Restricted Stock Awards¥20,000,000

Total Compensation*

Total Annual Cash Compensation¥142,000,000
Total Short Term Compensation¥142,000,000
Other Long Term Compensation¥20,000,000
Total Calculated Compensation¥162,000,000
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Michael W. Aguiar Chief Executive Officer, President, Director and Member of Stock Option Committee
Innoviva, Inc.
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
Peter S. Greenleaf Chairman and Chief Executive Officer
Sucampo Pharmaceuticals, Inc.
Eduardo Javier Sanchiz Yrazu Chief Executive Officer, Member of Management Board, Executive Director and Member of Compliance Committee
Almirall, S.A.
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact EISAI CO LTD, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.